Structure |
Chemical Name |
CAS |
MF |
|
Carvedilol Impurity 2 |
1198090-71-9 |
C18H17NO3 |
|
Clotrimazole Impurity 2 |
|
|
|
Dapagliflozin Impurity 33 |
|
|
|
Erlotinib Impurity 56 |
|
|
|
Moxifloxacin Impurity 8 |
1829588-19-3 |
C21H25N3O5 |
|
Olaparib Impurity 30 |
1460272-52-9 |
C24H21FN4O4 |
|
Pitavastatin Impurity 27 |
|
|
|
Pramipexole Impurity 24 |
|
|
|
Rocuronium Bromide Impurity 22 |
|
|
|
Tolterodine Impurity 1 |
88407-28-7 |
C22H31NO |
|
Voriconazole Impurity 7 |
239807-04-6 |
C16H14F3N5O |
|
AZD9291 Osimertinib Impurity 3 |
|
|
|
Dextrorotation lansoprazole Impurity K |
|
|
|
Doxofylline Impurity A |
|
|
|
lansoprazole Impurity 24 |
|
|
|
lansoprazole Impurity 30 |
|
|
|
meta-dyhydroxy Sugammadex sodium Impurity 2 |
|
|
|
Palbociclib Impurity 29 |
|
|
|
Palbociclib Impurity 34 |
|
|
|
Ropivacaine Impurity 38 |
|
|
|
Ropivacaine Impurity 43 |
2726971-51-1 |
|
|
Sugammadex sodium Decomposition process Impurity 1 |
|
|
|
Sugammadex sodium Org198786-1 Impurity |
|
|
|
Sugammadex sodium starting material Impurity 1 |
|
|
|
Fludarabine EP impurity H |
548774-57-8 |
C10H10FN5O3 |
|
Butyphthalide impurity 30 |
|
|
|
Cabozantinib impurity S |
|
|
|
Ticagrelor Impurity 39 |
|
|
|
Tofacitinib Impurity 109 |
|
|
|
Tofacitinib Impurity 114 |
|
|
|
Vildagliptin Impurity 34 |
1824265-77-1 |
C10H17NO3 |
|
1-(3-(benzyloxy)-5-hydroxyphenyl)-2-(tert-butylamino)ethan-1-one |
2459974-72-0 |
C19H23NO3 |
|
Demeclocycline EP Impurity C |
129044-45-7 |
C21H22N2O8 |
|
Brimonidine Impurity D |
|
|
|
Esmolol impurity D |
|
|
|
Diquafosol Impurity D |
|
|
|
Peramivir Impurity 11 |
|
|
|
Vildagliptin Impurity 6 |
|
|
|
Sunitinib Impurity 1 |
|
|
|
Erlotinib Impurity 18 |
|
|
|
Fasudil Impurity 6 |
1581642-06-9 |
C14H18ClN3O2S |
|
Rosuvastatin Impurity 56 |
|
|
|
Dapoxetine Impurity 4 |
|
|
|
Ticagrelor Impurity 17 |
|
|
|
Empagliflozin Impurity 13 |
|
|
|
Moxifloxacin Impurity 2 |
|
|
|
Cabozantinib Impurity 1 |
|
|
|
Febuxostat Impurity 56 |
|
|
|
Ambroxol Impurity 9 HCl |
|
|
|
Penicillin Impurity A |
|
|
|
Cefminox Sodium impurity A |
|
|
|
Cefotiam Impurity A |
|
|
|
pranoprofen impurity 25 |
|
|
|
Peramivir Impurity D |
|
|
|
Lincomycin sulfoxide Impurity 2 |
|
|
|
Lincomycin sulfoxide Impurity E |
|
|
|
Fasudil iMpurity E |
|
|
|
(+/-)-EPINEPHRINE SULFONIC ACID |
26405-77-6 |
C9H13NO5S |
|
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) |
112188-16-6 |
C14H22GdN4O6 |
|
((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester |
149709-58-0 |
C20H23NO3 |
|
1-(2,3-DiMethylphenyl)-1-(1H-iMidazol-4-yl)ethanol |
86347-12-8 |
C13H16N2O |
|
(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
1612153-32-8 |
C20H20FNO4 |
|
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
528565-93-7 |
C20H20FNO4 |
|
Posaconazole iMpurity 3 |
|
|
|
Bezafibrate Impurity D |
41859-58-9 |
C21H24ClNO4 |
|
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
C18H20ClN3O4S |
|
Ezetimibe Related Impurity 37 |
204589-68-4 |
C24H19F2NO2 |
|
S, R-Isovalganciclovir Impurity |
1356932-18-7 |
C14H22N6O5 |
|
Sofosbuvir Impurity 8 |
944476-44-2 |
C24H22N2O8 |
|
1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid |
1098100-87-8 |
C26H23N3O2 |
|
Fimasartan Impurity |
|
|
|
2-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)(methyl)amino)succinic acid |
|
C21H20FN3O6S |
|
2-(DIETHYLAMINO)-N-(2,4-DIMETHYLPHENYL)ACETAMIDE |
17289-53-1 |
C14H22N2O |
|
(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
C16H20N2O |
|
Oxaliplatin impurity |
|
|
|
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
|
Moxifloxacin Impurities |
|
|
|
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
|
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
|
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |
|
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
|
Etoricoxib Impurity 14 |
|
|
|
Riociguat Impurtiy 3 |
|
|
|
Trelagliptin Impurity 2 |
|
|
|
Chlorhexidine Impurity B |
1308292-89-8 |
C16H26ClN9O |
|
Dapoxetine Impurity D |
|
|
|
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
|
Lidocaine Impurity |
35891-84-0 |
C11H16N2O.ClH |
|
Pramipexole Impurity J |
|
|
|
Solifenacin Related Compound 14 |
605696-10-4 |
C25H30N2O2 |
|
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
|
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
|
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
|
Cefuroxime Sodium impurity D |
|
C16H16N4NaO8S |
|
Silodosin impurity A |
|
|
|
cefditoren △-3 isomer |
|
|
|
Ixazomib Impurity 1 |
1201903-02-7 |
C24H33BCl2N2O4 |
|
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
|
((4-Methoxyphenoxy)methylene)dibenzene |
85686-16-4 |
C20H18O2 |
|
Tofacitinib Impurity L |
|
|